Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells

被引:8
作者
Oh, Jun Y. Y. [1 ]
Osorio, Robert C. C. [1 ]
Jung, Jangham [1 ]
Carrete, Luis [1 ]
Choudhary, Nikita [1 ]
Lad, Meeki [1 ]
Saha, Atul [1 ]
Aghi, Manish K. K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA
关键词
pituitary; pituitary neuroendocrine tumors; pituitary adenomas; transcriptomics; scRNA-seq; Cushing; prolactinoma; gonadotroph; SOMATOSTATIN ANALOGS; DECREASED EXPRESSION; TRANSFORMING GENE; GSP MUTATIONS; DOPAMINE; ADENOMAS; BROMOCRIPTINE; PATHOGENESIS; RECEPTORS; RESISTANT;
D O I
10.3390/cancers15010110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The molecular pathogenesis of pituitary neuroendocrine tumors (PitNETs) involves the interplay of many genes and transcription factors in the setting of a diverse altered tumor microenvironment. Recent advancements in molecular technologies, such as single-cell RNA sequencing, became essential in delineating specific cell types and identifying altered genes in both normal physiological states and diseases in the pituitary. This review discusses the recent progress made in characterizing the transcriptomic profiles of the normal pituitary gland and sporadic PitNETs and their significance. The pituitary gland is one of the most cellularly diverse regions of the brain. Recent advancements in transcriptomic biology, such as single-cell RNA sequencing, bring an unprecedented glimpse into the molecular composition of the pituitary, both in its normal physiological state and in disease. Deciphering the normal pituitary transcriptomic signatures provides a better insight into the ontological origin and development of five types of endocrine cells, a process involving complex cascades of transcription factors that are still being established. In parallel with these observations about normal pituitary development, recent transcriptomic findings on pituitary neuroendocrine tumors (PitNETs) demonstrate both preservations and changes in transcription factor expression patterns compared to those seen during gland development. Furthermore, recent studies also identify differentially expressed genes that drive various tumor behaviors, including hormone hypersecretion and tumor aggression. Understanding the comprehensive multiomic profiles of PitNETs is essential in developing molecular profile-based therapies for PitNETs not curable with current treatment modalities and could eventually help align PitNETs with the breakthroughs being made in applying precision medicine to other tumors.
引用
收藏
页数:16
相关论文
共 114 条
  • [1] BIOCHEMICAL CHARACTERISTICS OF HUMAN PITUITARY SOMATOTROPINOMAS WITH AND WITHOUT GSP MUTATIONS - IN-VITRO CELL-CULTURE STUDIES
    ADAMS, EF
    LEI, T
    BUCHFELDER, M
    PETERSEN, B
    FAHLBUSCH, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) : 2077 - 2081
  • [2] Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors
    Alzoubi, Hiba
    Minasi, Simone
    Gianno, Francesca
    Antonelli, Manila
    Belardinilli, Francesca
    Giangaspero, Felice
    Jaffrain-Rea, Marie-Lise
    Buttarelli, Francesca Romana
    [J]. ENDOCRINE PATHOLOGY, 2022, 33 (04) : 494 - 505
  • [3] The proneural bHLH genes Mash1, Math3 and NeuroD are required for pituitary development
    Ando, Mitsushige
    Goto, Masanori
    Hojo, Masato
    Kita, Aya
    Kitagawa, Masashi
    Ohtsuka, Toshiyuki
    Kageyama, Ryoichiro
    Miyamoto, Susumu
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2018, 61 (03) : 127 - 138
  • [4] Somatic mutation of TRβ can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor
    Ando, S
    Sarlis, NJ
    Oldfield, EH
    Yen, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5572 - 5576
  • [5] Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity
    Arber, S
    Han, B
    Mendelsohn, M
    Smith, M
    Jessell, TM
    Sockanathan, S
    [J]. NEURON, 1999, 23 (04) : 659 - 674
  • [6] Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice
    Asa, SL
    Kelly, MA
    Grandy, DK
    Low, MJ
    [J]. ENDOCRINOLOGY, 1999, 140 (11) : 5348 - 5355
  • [7] Overview of the 2022 WHO Classification of Pituitary Tumors
    Asa, Sylvia L.
    Mete, Ozgur
    Perry, Arie
    Osamura, Robert Y.
    [J]. ENDOCRINE PATHOLOGY, 2022, 33 (01) : 6 - 26
  • [8] Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease
    Asuzu, David T.
    Alvarez, Reinier
    Fletcher, Patrick A.
    Mandal, Debjani
    Johnson, Kory
    Wu, Weiwei
    Elkahloun, Abdel
    Clavijo, Paul
    Allen, Clint
    Maric, Dragan
    Ray-Chaudhury, Abhik
    Rajan, Sharika
    Abdullaev, Zied
    Nwokoye, Diana
    Aldape, Kenneth
    Nieman, Lynnette K.
    Stratakis, Constantine
    Stojilkovic, Stanko S.
    Chittiboina, Prashant
    [J]. CELL REPORTS, 2022, 40 (08):
  • [9] Null Cell Adenomas of the Pituitary Gland: an Institutional Review of Their Clinical Imaging and Behavioral Characteristics
    Balogun, James A.
    Monsalves, Eric
    Juraschka, Kyle
    Parvez, Kashif
    Kucharczyk, Walter
    Mete, Ozgur
    Gentili, Fred
    Zadeh, Gelareh
    [J]. ENDOCRINE PATHOLOGY, 2015, 26 (01) : 63 - 70
  • [10] Pronostic and therapeutic consequences of Gsα mutations in somatotroph adenomas
    Barlier, A
    Gunz, G
    Zamora, AJ
    Morange-Ramos, I
    Figarella-Branger, D
    Dufour, H
    Enjalbert, A
    Jaquet, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) : 1604 - 1610